Principles for sharing the benefits associated with more efficient use of medicines not reimbursed through national prices. NHS England’s medicines optimisation clinical reference group has published a document setting out how NHS England can work with providers incentivise more efficient use of high cost drugs excluded from the national tariff.
The purpose of this TDA Medicines Optimisation Framework developed by the Trust Development Agency is to help NHS Trusts to review their approach to medicines optimisation and pharmaceutical srevices. The outcome will be used by the TDA to provide an assessment of the extent and quality of services provided by NHS Trusts.
The National Care Forum has published resources to improve medicines management in care homes. The pack includes guides for employers and patients, and assessment tools and guidance on preventing medication errors.
Optimising medicines use in care pathways using pharmacy support and the Medicines in Commissioning Toolkit (link) are two key interlinked resources that have been revised and updated to support commissioners to help ensure care pathways which involve medicines deliver improved patient outcomes, are safe, use clinical and cost effective treatment options, offer patient choice and the best patient experience.
The resources emphasise the delivery of QIPP and the NHS Outcomes Framework, and, above all, demonstrate how to maximise patient outcomes through medicines optimisation. Both will also be useful to service providers, helping them to identify and address medicines-related issues in service specifications and comply with Care Quality Commission (CQC) Outcome 9 (Medicines Management).
In the current, rapidly changing, NHS environment these documents will provide a valuable starting point for local discussions between pharmacists and commissioners about the benefits and practicalities of commissioning medicines management support and appropriate pharmaceutical care for patients prescribed complex long and short term medication regimens.
Optimising medicines use in care pathways Vs1Sep12 (LD).pdf
Report includes guidance and recommendations for health and social care professionals. The report calls for a patient-centred approach to designing care that helps people to best use their medicines. The use of MCA has come to be regarded as a panacea for medicines use and is often integrated into practice and service policy without giving due consideration to the alternatives available. RPS believes that leadership and appropriate incentives are required to promote change that supports patient capability, independence and re-ablement.